Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Amoy Diagnostics is a leading molecular diagnostics company based in China. It specializes in the development and production of precise in-vitro diagnostics (IVD) for oncology. Through innovative PCR testing, Amoy Diagnostics enables customized cancer therapies for patients on a global scale.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Amoy Diagnostics A is scheduled to report its next quarterly earnings on 10/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Amoy Diagnostics A last reported quarterly earnings on 7/31/2026 (Q2 2026). Earnings per share (EPS) came in at 0.21 CNY.
Amoy Diagnostics A has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.